Metastatic Breast Cancer Treatment Market Trends

  • Report ID: 2998
  • Published Date: Dec 23, 2024
  • Report Format: PDF, PPT

Metastatic Breast Cancer Treatment Market Trends

Growth Drivers

  • Rising Prevalence of Breast Cancer
  • Increasing Investment in R&D

Challenges

  • Risk of Adverse Effects of Radiation Exposure
  • Lack of Awareness

 

Metastatic Breast Cancer Treatment Market: Key Insights

Geographically, the market is segmented into North America, Latin America, Europe, Asia Pacific and the Middle East & Africa region. The market in the Asia Pacific is predicted to grow at the highest CAGR over the forecast period owing to the increasing breast cancer prevalence and the rising geriatric population in the region. Furthermore, in 2021, the market in North America is evaluated to occupy the largest share in terms of revenue, owing to the growing healthcare investment, accompanied by the presence of leading healthcare service providers, and the increasing prevalence of cancer in the region. Along with this, the countries in North America such as the United States is promoting campaigns for breast cancer patients, which is also expected to contribute to the market growth in the region. According to the report published by the National Cancer Institute, in 2020, 1.8 million new cancer cases were registered in the United States. Such increasing rate of cancer is further expected to drive the demand for metastatic breast cancer treatment in the North American countries. Alternatively, the market in Europe is also anticipated to occupy a significant share in the global metastatic breast cancer treatment market on account of its proven success in terms of technology development and a high prevalence of breast cancer in the region. As per the analysis of the Globocan, 0.53 million new breast cancer cases were registered in the European Union, with 0.14 million deaths in 2020. Such growing number of deaths due to breast cancer is expected to increase the R&D activities to develop better treatment in the market.

Metastatic-Breast-Cancer-Treatment-Market-Share

The global metastatic breast cancer treatment market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Base Year

2024

Forecast Year

2025-2037

CAGR

10.2%

Base Year Market Size (2024)

USD 22.46 billion

Forecast Year Market Size (2037)

USD 79.39 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 2998
  • Published Date: Dec 23, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of metastatic breast cancer treatment is evaluated at USD 24.41 billion.

Metastatic Breast Cancer Treatment Market size was valued at USD 22.46 billion in 2024 and is set to exceed USD 79.39 billion by 2037, registering over 10.2% CAGR during the forecast period i.e., between 2025-2037.

Asia Pacific industry is likely to account for largest revenue share by 2037, owing to increasing breast cancer prevalence, and rising geriatric population in the region.

The major players in the market are F. Hoffmann-La Roche Ltd, Merck & Company, Inc., AstraZeneca Plc., Novartis, Amgen Inc., Pfizer Inc., Eli Lilly and Company, Sun Pharmaceutical Industries Limited, Johnson & Johnson, GlaxoSmithKline plc., and others.

Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample